Market-Moving News for September 23rd
Market-Moving News for September 23rd
BDTX: 54% | Black Diamond Therapeutics shares are trading higher after the company announced initial Phase 2 data demonstrating encouraging clinical responses and durability of BDTX-1535 in patients with relapsed/refractory epidermal growth factor receptor-mutant non-small cell lung cancer.
BDTX: 54% | black diamond therapeutics股價上漲，因該公司宣佈了初步2期數據，顯示BDTX-1535對復發/難治表皮生長因子受體突變非小細胞肺癌患者具有鼓舞人心的臨床反應和持久性。
VTYX: 42% | Ventyx Biosciences Announces Sanofi Has Agreed To Make A $27M Investment In Co. At An As-Converted Price Of $3.8243 Per Share, Pursuant To Which Sanofi Will Purchase 70,601 Shares Of Series A Non-Voting Convertible Preferred Stock
VTYX: 42% | Ventyx Biosciences宣佈賽諾菲安萬特已同意以每股3.8243美元的轉換價格對公司進行2700萬美元的投資，根據協議，賽諾菲將購買70,601股A系列無表決權可轉換優先股。
BHVN: 26% | Biohaven shares are trading higher after the company announced its study of Troriluzole for the treatment of spinocerebellar ataxia in achieved the primary endpoint.
BHVN: 26% | biohaven股價上漲，因該公司宣佈其關於Troriluzole用於治療脊髓小腦共濟失調的研究達到了主要終點。
譯文內容由第三人軟體翻譯。